dm+d
108624006
Articles
Safety in Lactation: Topical nasal decongestants
27 October 2020Drugs used for nasal decongestion have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence…
Safety in Lactation: Drugs for obstructive airways disease
25 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to…
Which commonly used nebuliser solutions are compatible?
27 February 2020Mixing of nebuliser solutions should only be undertaken in the best interests of the patient and only by a person competent and willing to do…
Ethanol content of inhalers – What is the significance?
13 December 2019Ethanol is included as an excipient in many commonly prescribed inhalers, including some licensed for use in children. Patients may have ethical, religious or cultural…
Hypersalivation - what are the treatment alternatives to glycopyrronium and hyoscine?
1 August 2018This Medicines Q&A outlines possible alternatives to hyoscine hydrobromide and glycopyrronium in the treatment of non drug-induced hypersalivation, e.g. botulinum toxin, amitriptyline, atropine (eye drops…
Lactation Safety Information
Inhalation
Inhalation
-
Antimuscarinic bronchodilator
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Used in infants >1 month
31 July 2020
Intranasal
Intranasal
31 July 2020